Please read the CE information below, then click the "Begin Activity" button to continue.
CE Information
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC), and Catamount Medical Education.
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
This activity can take up to 1 hour to complete.
Release/Expiration Dates
Releases on: July 24, 2026
Expires on: July 24, 2027
Target Audience
This activity is intended for neurologists, advanced practice nurses, PAs, nurses, pharmacists, and other members of the healthcare professional team who care for people with MS.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply the current McDonald criteria to ensure the early and accurate diagnosis of MS
- Incorporate evidence-based decision-making in therapy selection by considering disease characteristics, drug efficacy and safety profiles, and patient-related factors including comorbidities and preferences
- Evaluate clinical measures and biomarkers of disease activity to guide decisions about treatment switching or modification
Faculty
Robert J. Fox, MD
Neurologist
Mellen Center for Multiple Sclerosis
Neurological Institute
Cleveland Clinic
Cleveland, Ohio
Scott Newsome, DO, MSCS, FAAN, FANA
Professor of Neurology
Director, Johns Hopkins Stiff Person Syndrome Center of Excellence
Director, Neurosciences Consultation and Infusion Center at Green Spring Station
Director, Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program
Co-Director, Multiple Sclerosis Experimental Therapeutics Program
Member, Miller-Coulson Academy of Clinical Excellence
Johns Hopkins
Baltimore, Maryland
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC), and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physicians
The CMSC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The CMSC designates this activity for a maximum of 1.0 nursing continuing professional development (NCPD) credits (1.0 in the area of pharmacology).
Pharmacists
This knowledge-based activity, UAN JA4008165-9999-26-023-H01-P qualifies for 1.0 contact hours (.10 CEUs) of continuing pharmacy education credit.
All other health care professionals completing this course will be issued a statement of participation.
Request for Credit
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 3 weeks.
Disclosures of Financial Relationships
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC and Catamount Medical Education require that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. CMSC and Catamount Medical Education mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC and Catamount Medical Education seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC and Catamount Medical Education are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.
Faculty Disclosures
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Robert J. Fox, MD
Advisory Board: AB Science; Biogen; Immunic; Novartis Pharmaceuticals; Sanofi
Consulting: AbbVie; Astoria Biologica; Biogen; Bristol Myers Squibb; Galvani; Immunic; Innocare; Kiniksa; Novartis Pharmaceuticals; Sanofi; SetPoint Medical; Sudo Biosciences; TG Therapeutics
Contracted Research: Sanofi; Synaptogenix
Scott Newsome, DO, MSCS, FAAN, FANA
Advisory Board: Genentech; Roche; Sanofi; TG Therapeutics
Consulting: Novartis Pharmaceuticals
Contracted Research: Biogen; Genentech; Kyverna; Lundbeck; Roche; Sanofi
Activity Staff Disclosures
Kathleen Costello, CRNP, MSCN, and Laurie Scudder, DNP, NP, served as planners and reviewers and have disclosed no relevant financial relationships.
How to Participate in This Activity and Obtain CE Credit
There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must:
- Read the CE information
- Complete the pretest
- View the content
- Complete the posttest and the evaluation form
A score of 67% (2 out of 3) correct must be achieved on the posttest to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the posttest. You may retake the posttest until successful. Upon completion of the evaluation, your certificate will be emailed to you.
Our Policy On Privacy
The Consortium of Multiple Sclerosis Centers and Catamount Medical Education, LLC, respect your privacy. All personal information that is provided to Catamount Medical Education, LLC, is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC, registration databases are treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC, maintains user databases that contain mailing and user profile information as well as a record of the CME activities viewed and the posttest and evaluation results for CE credit. This information is provided to activity collaborators for the purposes of CE recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC, has full permission to provide this information.
Catamount Medical Education, LLC, safeguards against the loss, misuse, or alteration of information that we have collected in this activity.
Disclosure of Unlabeled Use
CMSC and Catamount Medical Education require CE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For questions about this activity, please contact Catamount Medical Education at info@catmeded.com.
In conjunction with the 2026 Annual Meeting of the CMSC.